Your 108 Expert Speakers

Ahmed Bassyouni

Independent Consultant

Amy Han

Solid Tumor Targeted Therapies & Commercial Disease Area Leader

Regeneron

Amy Peterson

Executive Vice President & Chief Development Officer

CytomX

Andreas Pahl

Chief Scientific Officer

Heidelberg Pharma

Andrew Mayer

Scientific Leader

GlaxoSmithKline

Andrew Philips

Director of Next Generation Drug Conjugates

AbbVie

Ann MacLaren

Executive Director, Translational Development

Triphase Accelerator

Anton Rosembaum

Head of Regulated Bioanalysis & OMICS by LC-MS within Integrated Bioanalysis

AstraZeneca

Antonio Palumbo

MD Global Medical Expert

GlaxoSmithKline

Aubrey Morgart

ADC Patient

Audrey Bendelac

ADC Scientific Manager, Process Development

Sanofi

Ben-Quan Shen

Principal Scientist

Genentech

Brian Clark

Independant Consultant

GMP Consulting

Brian Mendelsohn

Senior Director

Exelixis

Brian O’Mara

Associate Director - Downstream Process Development

Ambrx

Brian Safina

Vice President – Chemistry

Bolt Biotherapeutics

Carmen Juds

Senior Scientist - Process Development Bioconjugates

Lonza

Chee Ng

Associate Professor & Research Investigator

University of Kentucky

Chet Bohac

Senior Medical Director

Macrogenics

Chris Scott

Professor - Pharmaceutical Biosciences

Queen’s University Belfast

Christian Behrenbruch

Managing Director & Chief Executive Officer

Telix Pharmaceuticals

Christine Knuehl

Translational and Biomarker Research Leader, TIP Oncology & Immuno-Oncology

Merck KGaA Darmstadt Germany

Conor Barry

Head of Development

Piramal Pharma Solutions

Daisuke Okajima

Scientist, Preclinical Pharmacology, Oncology

Daiichi Sankyo

David Goeddel

Director of API R&D

Millipore Sigma

David Newman

Independent Consultant

David Ungar

Head of US Oncology Clinical Development

ADC Therapeutics

Donald Mager

Professor & Vice Chair of Pharmaceutical Sciences

University at Buffalo

Dong Wei

Associate Director - Bioanalytical, Biomarker, Drug Metabolism & Pharmacokinetics

Takeda

Donna W. Lee

Principal Scientist / Toxicologist Dept of Safety Assessment

Genentech

Douglas A Levine

Senior Principal Scientist, Early Oncology Development

Merck Research Labs

Earl Albone

Senior Director, Biochemistry Discovery

Eisai

Ed Ha

Founding Principal Scientist - Antibody Drug Conjugates

AngieX

Edit Tarcsa

Director, Research Fellow DMPK-BA,

Abbvie

Emily Stevens

Medical Director of Tactical Biomarker Team

Seagen

Emmett Schmidt

Vice President, Clinical Research, Lead, External Collaborations, Oncology Early Development

Merck

Engin Ayturk

Sr. Director, CMC Process Engineering & BioConjugation

Mersana

Evelyn Van Den Tweel

Project Leader, Clinical Development

Byondis

Federico Riccardi Sirtori

Director, Head of NBE-DMPK Innovative Bioanalytics

Merck KGaA

Fredrik Frejd

Chief Scientific Officer

Affibody

Erik Johansson

Principal Data Scientist, Data Science EMEA

Sartorius Stedim Data Analytics AB   

Francesco Bonardi

Director Bioanalysis

Ardena

Funda Meric-Bernstam

Department Chair, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine

MD Anderson Cancer Center

Gail Lewis Philips

Principal Scientist, Discovery Oncology

Genentech

Germo Gericke

Chief Medical Officer, Advanced Accelerator Applications, a Novartis company

Advanced Accelerator Applications

Gilles Gallant

Senior Vice President, Global Head of Oncology Development, Oncology R&D

Daiichi Sankyo

Giorgio Salciarini

Senior Manager – Technical, Business Development

BSP Pharmaceuticals

Greg Thurber

Associate Professor

University of Michigan

Haowei Song

Principal Scientist

MilliporeSigma

Hetal Sarvaiya

Associate Director, Biologics Bioanalysis, DMPK-BA

AbbVie

Horst Bierau

Senior Scientific Advisor – Head CMC Science & Intelligence

Merck KGaA

Janice Darlington

Customer Engagement Scientist

Collaborative Drug Discovery

Jay Harper

Associate Director - Research Onocology

AstraZeneca

Jeiwook Chae

Chief Business Development Officer

Legochem Biosciences

Jia He

Senior Research Analyst

Beacon Targeted Therapies

John Lambert

Independent Consultant

Attager Consulting

John Rolf

Director, Product Quality

Seagen

John Valliere Douglass

Associate Director

Seagen

Juan Carlos Cordova

Director, Process Development

Abzena

Justin Mason-Home

Director

HPAPI Project Services Limited

Justin Oh

Chief Business Officer

AbTis

Kshitij Khatri

Investigator

GlaxoSmithKline

Leo Nicacio

Vice President - Clinical Development

Seagen

Lisa Mcdermott

Director - Process, Analytical Development & Senior Manager

MilliporeSigma

Marc Damelin

Vice President, Biology

Mersana

Manish Hudlikar

Scientist, Chemistry & Bioconjugates

Angiex, Inc

Marie Zhu

Chief Technology Officer

Remegen

Martha Neagu

Associate Medical Director - Physician Development Program

AbbVie

Megan O’Meara

Vice President, Head of Early Stage Development

Seagen

Mingchao Kang

Project Leader, EuCode

Ambrx

Michael Method

Executive Medical Director

ImmunoGen

Minmin Qin

Senior Vice President of CMC

Miracogen

Nathan Tumey

Assistant Professor, Pharmaceutical Sciences

Binghamton University

Neil Bander

Professor, Bernard and Josephine Chaus Chair in Urological Oncology, & Director of Urological Oncology Research

Weill Cornell Medicine

Olga Ab

Product Lead IMGN151 and IMGC936

ImmunoGen

Patrick Groothuis

Principal Scientist - In Vivo Pharmacology, Toxicology, Drug Metabolism & Pharmacokinetics

Byondis

Paul Song

Chief Scientific Officer

Genequantum

Philip Howard

Chief Scientific Officer

Spirogen

Puja Sapra

Vice President, Head of Tumor Targeted Delivery, Oncology R&D

AstraZeneca

Rakesh Dixit

President & Founder

Bionavigen

Raphael Eric Steiner

Assistant Professor in the Department of Lymphoma & Myeloma

University of Texas MD Anderson Cancer Center

Rob Straubinger

Professor of Pharmaceutical Sciences

University at Buffalo

Robert Lutz

Chief Science Officer

Iksuda

Roee Ramot

Research Scientist II

Novartis Institute for Biomedical Research (NIBR)

Rolf Werner

Chief Operation Officer

Genequantum Healthcare Co Ltd

Ruud Coumans

Project Leader Antibody-Drug Conjugates

Byondis

Scott Patterson

Vice President, PharmBio, Technical Support

ILC Dover

Scott Tagawa

Professor of Medicine & Professor of Medicine in Urology

Weill Cornell Medicine

Sean Smith

Executive Director of Chemistry

Silverback Therapeutics

Seema Kantak

Vice President, Biologics & Biotherapeutics

Exelixis

Shelley Ackerman

Associate Director & Project Team Lead

Bolt Biotherapeutics

Steffen Wöll

Principal Scientist

Merck

Steven Conlan

Professor of Molecular and Cellular Biology

Swansea University Medical School

Sukumar Sakamuri

Vice President, Head of Chemistry

Ambrx

Susan Clardy

Senior Scientist - Analytical Chemistry, Manufacturing & Control

Mersana

Tae Kyo Park

Chief Executive Officer

Intocell

Tim Lowinger

Chief Scientific Officer

Mersana

Valerie Odegard

President & Chief Scientific Officer

Silverback Therapeutics

Victor Yip

Principal Scientific Researcher

Genentech

Violet Lee

Scientist

Genentech

Vítor Sousa

BD Manager

Cerbios Pharma

Yuki Matsuno

Researcher

NOF CORPORATION

Yun Kim

Director of Protein Science

Catalent

Yutaka Matsuda

ADC Researcher

Ajinomoto Bio- Pharma Services

Yuyi Shen

Director, Process development and Manufacturing

Bolt Biotherapeutics

Patrick Zweidler-McKay

Senior Medical Director

ImmunoGen

Zhala Tawfiq

Process Development & TT Associate Scientist

Ajinomoto Bio- Pharma Services

Zhibo Lui

Principle Investigator

Peking University